Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Affinia Therapeutics to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
-
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
-
ProQR to Participate in Upcoming Investor Conferences in October 2025
-
ARTHEx Biotech to Participate in Upcoming Investor and Industry Events
-
Prime Medicine to Participate in Upcoming Investor Conferences
-
Editas Medicine to present EDIT-401 data at gene therapy congress
-
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
-
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
-
Ocugen to Present at Industry and Investor Conferences in October 2025
-
ZOOZ purchases 525 bitcoin for $60 million following shareholder approval
-
Zooz Completes $60 Million Bitcoin Purchase
-
ZOOZ completes $60 million bitcoin purchase after shareholder approval
-
ZOOZ Completes Initial Purchase of ₿525 Valued at $60 Million, Becomes the First Dual-listed (Nasdaq and TASE) Company to Launch a Bitcoin Treasury Reserve Strategy
-
Sonim Technologies enters equity facility agreement with Chardan
-
Chardan Capital Markets Starts Reviva Pharmaceuticals (RVPH) at Buy, PT $2
-
Chardan Capital Markets Starts Alto Neuroscience (ANRO) at Buy, PT $15
-
Chardan Capital Markets Starts Immunic Inc. (IMUX) at Buy, PT $3
-
AlphaTON Capital raises $71 million, acquires $30 million in TON tokens
-
AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
-
Kodiak completes SPAC merger, to begin trading on NASDAQ as KDK
-
Kodiak Completes Business Combination with Ares Acquisition Corporation II to Accelerate Journey as a Leading AI-Powered Autonomous Vehicle Technology Company
-
ZOOZ Shareholders Approve Previously Announced $180 Million Private Placement and Bitcoin Treasury Reserve Strategy, Along with All Related Proposals
-
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
-
Apnimed to Participate in Upcoming September Investor Conferences
-
Chardan Capital Markets Starts Ocular Therapeutix (OCUL) at Buy
-
WestPark Capital Announces the Hiring of Priyanka Mahajan as Managing Director of Investment Banking
-
Chardan Capital Markets Downgrades Tourmaline Bio (TRML) to Neutral
-
AlphaTON Capital raises $100 million to build TON digital asset treasury
-
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
-
AlphaTON Capital raises $73M to build TON token treasury
-
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
-
BT Brands to merge with drone services company Aero Velocity
-
BT Brands and Aero Velocity Announce Execution of Definitive Merger Agreement
-
US FDA declines to approve Outlook Therapeutics' eye disease drug, shares plummet
-
Krystal Biotech (KRYS) PT Lowered to $216 at Chardan Capital Markets
-
Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell
-
Prime Medicine (PRME) PT Lowered to $10 at Chardan Capital Markets, 'Cash Runway Breathing Room'
-
SAB Biotherapeutics (SABS) PT Lowered to $12 at Chardan Capital Markets
-
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
-
Senti Bio reports Q2 2025 results, confirms AML data expected Q4
-
Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025
-
Sensorion Announces Its Participation In Upcoming Investor Conferences
-
Form D Chardan Holdings LP
-
ZOOZ Announces Private Placement of $180 Million to Launch a Bitcoin Treasury Reserve Strategy
-
SAB BIO Announces Oversubscribed $175 Million Private Placement
-
Smith Micro Announces Closing of Follow-On Offering
-
Chardan Capital Markets Downgrades Clearside Biomedical (CLSD) to Neutral
-
Smith Micro raises $1.5 million through stock offering and warrants
-
Bit Origin raises $500 million to build dogecoin treasury strategy

